Pricing Log in Create free account
Saturday 17 October 2026 Export MCK’s income statement to Excel — free account

McKesson Corporation

MCK Healthcare Medical Distribution

McKesson Corporation’s revenue for fiscal 2026 (year ended March 2026) was $403.4 billion, up 12.4% from fiscal 2025. In the quarter to June 2026, revenue grew 7.72%, EPS fell 17.7%, free cash flow grew 66.4% and total debt rose 10.5%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years, revenue growth for ten.

1,006.92 8.28 +0.83%
Market cap
$116.4B
P/E
26.8×
Fwd P/E
18.3×
Dividend yield
0.34%
F-score
7/9
Altman Z
6.15
Beneish M
−2.34
Dividend safety
86/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

McKesson Corporation (MCK) P/S ratio

Alert me on P/S ratio

As of 16 October 2026, McKesson Corporation (MCK) trades at a P/S ratio of 0.3×. Over the past ten years it has ranged from 0.1× (March 2020) to 0.3× (May 2015); the current reading is higher than 96% of that period. That is above the Medical Distribution industry median of 0.3× and below the Healthcare sector median of 3.4×.

P/S ratio, daily

Embed this chart

Annual newest first

Period P/S ratio Change
FY2026 0.3× 11.01%
FY2025 0.2× 3.24%
FY2024 0.2× 27.37%
FY2023 0.2× 2.83%
FY2022 0.2× 34.30%
FY2021 0.1× 24.41%
FY2020 0.1× (2.85%)
FY2019 0.1× (22.06%)
FY2018 0.1× (15.39%)
FY2017 0.2× (12.93%)

Quarterly newest first

Period P/S ratio Change
Jun 2026 0.2× (17.69%)
Mar 2026 0.3× 4.41%
Dec 2025 0.3× 2.59%
Sep 2025 0.2× 2.10%
42 more quarters

Against its own ten years

Low 0.1× High 0.3×
Ten-year median 0.2×
Current reading's percentile 99

P/S ratio against peers

Company P/S ratio
ACH Accendra Health, Inc. compare 0.0×
COR Cencora, Inc. compare 0.2×
CAH Cardinal Health, Inc. compare 0.2×
COSM Cosmos Health Inc. compare 0.3×
MCK McKesson Corporation 0.3×
HSIC Henry Schein, Inc. compare 0.7×
AHG Akso Health Group Sponsored ADR compare 1.1×
FOCL FocalTherics compare 1.9×
HKPD Cellyan Biotechnology Co., Ltd compare —
Medical Distribution industry median 0.3×
Healthcare sector median 3.4×
Market median 1.9×

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

More on MCK